Contrary to your opinion, I see plenty of evidence that the funds will be used to complete the transition of Colostat to an IVDR-compliant product (requires $1.5 mil as outlined in the Prospectus). Previously the company successfully completed 7 clinical trials, alongside a range of other significant tangible activities, it's hardly a sham. The Directors receive standard remuneration, plus they own substantial shares, including full entitlements purchased in the capital raise, which I'm absolutely sure they'd like to see increase in value. As it stands, with a 38% uptake, the shares haven't been diluted quite so much, which partly offsets the challenges associated with having raised less funds.
- Forums
- ASX - By Stock
- Ann: Close of Rights Issue
Contrary to your opinion, I see plenty of evidence that the...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.8¢ |
Change
0.004(6.25%) |
Mkt cap ! $16.90M |
Open | High | Low | Value | Volume |
6.8¢ | 6.8¢ | 6.8¢ | $1.236K | 18.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 40569 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.066 |
1 | 31000 | 0.064 |
1 | 200000 | 0.062 |
2 | 24000 | 0.056 |
1 | 9091 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 40569 | 2 |
0.070 | 155714 | 4 |
0.071 | 117305 | 2 |
0.072 | 2245 | 1 |
0.079 | 12495 | 1 |
Last trade - 10.14am 21/08/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online